Barbara Deschler-Baier

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies

Patrick Schöffski, Daniel Shao-Weng Tan, Miguel Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Pasotuxizumab, a Bite ^® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich et al. · Immunotherapy · 2020 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.

Barbara Deschler-Baier, Théo de Witte, Roland Mertelsmann et al. · PubMed · 2006 · 139 citations

Medicine, Hematology, Oncology +14

Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis

Barbara Deschler-Baier, Gabriele Ihorst, Susanne Schnitzler et al. · Bone Marrow Transplantation · 2018 · 81 citations

Medicine, Geriatric Medicine, Hematology +16

Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients

Martina Kleber, Gabriele Ihorst, Barbara Deschler-Baier et al. · European Journal Of Haematology · 2009 · 71 citations

Medicine, Nephrology, Oncology +17